PharMolix — Industry leader in bio-medical foundation-model and intelligent-agent platforms

AutoPilot + CoPilot
Redefining the drug-discovery paradigm

Multimodal Foundation Models

Suite includes BioMedGPT-R1 (open source model), PharMolix-FM (all-atom model), and ChatDDFM®(reasoning model).

End-to-end Intelligent Agents

Next-gen drug-development agents: ChatDD-Insight, ChatDD-Discovery, and ChatDD-Trial.

Agent Knowledge Graph

PharMolixKG fuses tens of millions of vetted entities with billions of relations, redefining knowledge graphs for large-model workflows.

Open-source Multimodal Bio-medical Model

Open-source Multimodal Bio-medical Model

BioMedGPT-R1—the world's first open-source multimodal reasoning model for biomedicine—delivers top-tier performance, achieving USMLE accuracy on par with proprietary systems and human experts.

All-atom Foundation Model

PharMolixFM unifies multimodal data at atomic resolution, scoring 83.9 % (self-rank) and 98.1 % (oracle) on PoseBusters and setting SOTA for binding affinity + drug-likeness on CrossDocked.

Bio-medical Reasoning Model

ChatDDFM®, a commercial multimodal reasoning model enriched with life-science knowledge, boosts planning ability and slashes R&D cost. It outperforms peer models in professional medical Q&A.

ChatDD-Insight

Powered by PharMolixKG and multimodal RAG, we deliver benchmark-beating answers and deep insights for project initiation and strategic decisions.

Learn More

ChatDD-Discovery

One platform covers target discovery, molecular design, screening, optimization, and reporting—driven by conversational AI and proprietary cutting-edge tech—to accelerate novel-drug R&D.

Learn More

ChatDD-Trial

Foundation models streamline clinical research end-to-end: medical writing, data management, trial operations, pharmacovigilance, AE prediction, real-world evidence, indication mining, and more.

Learn More